Project: Molecularly imprinted nanofluidic biosensors for the detection of human derived proteins

Acronym MINaFBioS (Reference Number: MNET19/ADMA-3683)
Project Topic MINaFBioSen project intends to associate the molecularly imprinting technology to the assemblies of conducting polymers and graphene, and to generate specificity to certain human derived proteins – a totally new approach of what molecularly imprinting technology represents now. MINaF-BioSen will perform the electrochemical simulation, design and development of integrated nano-fluidic sensing technology and achieve the laboratory proof of concept. MINaF-BioSen will offer an innovative feasible solution of a testing device for monitoring of beta-amyloid peptide from Alzheimer’s Disease patients. Under the global Alzheimer’s Disease market, predicted to reach $14.8 billion by 2026, the project support to the development of the European know-how on integrated biosensors and related bioelectronics may bring an important economic advantage for EC by comparing to actual situation on market, led by North America and Japan.
Network MANUNET III
Call MANUNET CALL 2019

Project partner

Number Name Role Country
1 Intelectro Iasi SRL Partner Romania
2 MATEPRINCS SL Partner Spain
3 NAITEC (FUNDACION I+D AUTOMOCION Y MECATRONICA) Partner Spain
4 National Institute of Materials Physics Coordinator Romania
5 "Gheorghe Asachi" Technical University of Iasi Partner Romania